Navigation Links
VIVUS Reports First Quarter 2011 Financial Results
Date:5/2/2011

ons contained in the label and the extent of the Risk Evaluation and Mitigation Strategies program; uncertainties of litigation and intellectual property and patent protection; reliance on sole-source suppliers; limited sales and marketing resources and dependence upon third parties; risks related to the development of innovative products; risks related to the failure to obtain FDA or foreign authority clearances or approval; noncompliance with FDA or foreign regulations; and our dependence on the performance of our collaborative partners. As with any pharmaceutical in development, there are significant risks in the development, the regulatory approval, and commercialization of new products. There are no guarantees that our response to the FDA's CRL or the results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy and subsequent meetings and communications will be sufficient to satisfy the FDA's safety concerns, that the FDA will not require us to conduct any additional  prospective studies or retrospective observational studies, or that any product will receive regulatory approval for any indication or prove to be commercially successful. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2010, and periodic reports filed with the Securities and Exchange Commission.VIVUS, Inc.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share amounts)(unaudited)Three Months EndedMarch 31March 3120112010Operating expenses:Research and development$
4,480$
,211General and administrative5,4285,164Total operating expenses9,90815,375Loss from operations(9,908)(15,375)Interest and other income (expense), net

42(1,233)Loss from continuing operations before income taxes(9,866)(16,608)Provision for income taxes(1)(1)Net loss from cont
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. VIVUS to Present at Four Upcoming Investor Conferences in May
2. VIVUS to Present at the 10th Annual Needham Healthcare Conference
3. Data on VIVUS QNEXA to be Presented in Six Posters at The Obesity Societys Annual Meeting
4. VIVUS to Present at Four Upcoming Investor Conferences
5. VIVUS to Present at Two Upcoming Investor Conferences
6. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
7. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
8. VIVUS to Present at Four Upcoming Healthcare Conferences
9. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
10. VIVUS to Present at the Needham and Company Life Sciences Conference
11. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... ATCC, the premier global biological materials ... important appointments to the senior leadership team. Barbie Bigelow ... and Technology and Dr. Maryellen de Mars also joins ... Both roles are new positions at ATCC. ... at ATCC described the additions as part of a ...
(Date:9/23/2014)... 2014  Age Defying Dermatology ® , owned and ... one of the first clinics in the Bay Area ... for tattoo removal. The treatment safely and effectively erases ... tattoo removal has been a lengthy, painful, and all ... an opportunity to erase tattoo pigment more efficiently with ...
(Date:9/23/2014)... , Sept. 23, 2014   GenoSpace , ... comprehensive suite of tools to enable the broad use ... announced that it has been awarded Phase I of ... from the National Institutes of Health (NIH) to enable ... Logo - http://photos.prnewswire.com/prnh/20140922/147649 ...
(Date:9/23/2014)... 2014 Healthcare professionals, patients ... convene at the Society for Integrative Oncology ... October 26-28 in Houston, Texas to discuss ... in individualized integrative cancer care. This multi-disciplinary ... nutritionists, naturopaths, acupuncturists, and other complementary care ...
Breaking Biology Technology:ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... Solution Supports Integration of Cardium Health, AirLogix, and Work/Life ... ... Company, BEDFORD, Mass., March 4 ... today,that Nurtur, a subsidiary of Centene Corporation (NYSE: CNC ), ...
... Progress at Seneca, Illinois ... Biodiesel Refinery, ... announced today that it has satisfied the conditions precedent,and completed its ... facility with WestLB AG, one of the world,s leading,financial services providers ...
... 2008 Lets eHarmony Forget About Storage and Focus on ... leading clustered NAS,systems provider, announces the launch of ExaStore ... needs in a full range of,applications and environments., ... storage,requirements, creating a considerable burden," says Dr. Arnon Gat, ...
Cached Biology Technology:Nurtur(TM) Selects CaseNET to Enable Integrated Health and Life Management Capabilities 2Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility 2Exanet Announces ExaStore 2008 Clustered NAS System 2
(Date:9/23/2014)... measure the effects of temperature on insects to predict ... but a Dartmouth study shows for the first time ... temperature, ultimately limits how fast they grow. , "In ... the overall environmental conditions that shape the growth, survival ... Lauren Culler , an Arctic postdoctoral researcher at ...
(Date:9/23/2014)... are fighting a cyberwar against cancer finds that the ... , "Recent research has found that cancer is already ... we studied the interplay between cancer and the immune ... on cancer," said Rice University,s Eshel Ben-Jacob, co-author of ... of the Proceedings of the National Academy of ...
(Date:9/23/2014)... Ill. Scientists have scoured cow rumens and termite ... cell walls for the production of next-generation biofuels, but ... in the human lower intestine, researchers report. , Their ... the National Academy of Sciences , is the first ... microbes in the human gut can digest fiber, breaking ...
Breaking Biology News(10 mins):Insects' fear limits boost from climate change, Dartmouth study shows 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3
... N.C. -- Under a landmark agreement signed this week, ... an independent foundation at the Nicholas School of the ... new home, Duke Environment Hall. Research collaborations, ... legendary scientist E.O. Wilson are among the initiatives that ...
... turn parts of our genome off and on at strategic ... cells act and are impacted by environmental factors including diet, ... that aging also effects the epigenome in human skeletal muscle. ... provides a method to study sarcopenia, the degenerative loss ...
... of arsenic exposure regardless of arsenic concentrations in drinking and ... also confirms that toenail clippings are a good biomarker of ... dark meat fish. Exposure to arsenic has been linked to ... low birth weight. The findings appear in ...
Cached Biology News:E.O. Wilson Biodiversity Foundation moving to Duke 2Aging impacts epigenome in human skeletal muscle 2Dartmouth-led study shows diet alone can be significant source of arsenic 2